CANDESARTAN

CANDESARTAN was reported 36300 times

CANDESARTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 88 0.5906
1 CARDIOSPASM 275 0.4928
2 HYPOCHOLESTEROLAEMIA 165 0.4674
3 IMMUNISATION 176 0.4055
4 PALMOPLANTAR KERATODERMA 267 0.3683
5 PULMONARY VASCULITIS 190 0.3532
6 TOTAL LUNG CAPACITY ABNORMAL 125 0.3213
7 FACET JOINT SYNDROME 943 0.2894
8 CAPILLARITIS 72 0.2609
9 ANTACID THERAPY 33 0.2538
10 NEOVASCULARISATION 59 0.2243
11 SPIROMETRY ABNORMAL 130 0.2174
12 NEUROLOGIC NEGLECT SYNDROME 119 0.2140
13 PERIPHERAL VENOUS DISEASE 839 0.2052
14 CONGENITAL HIATUS HERNIA 45 0.1974
15 CARDIAC OUTPUT INCREASED 33 0.1930
16 BLOOD LACTIC ACID DECREASED 33 0.1919
17 MALIGNANT MELANOMA STAGE 0 38 0.1818
18 MITE ALLERGY 117 0.1786
19 ONYCHOMADESIS 701 0.1669
20 STEROID DEPENDENCE 140 0.1595
21 BLEPHAROSPASM 990 0.1571
22 SLEEP DISORDER THERAPY 31 0.1566
23 BREAST CANCER STAGE III 1010 0.1558
24 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 138 0.1489
25 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 109 0.1487
26 CATARRH 133 0.1471
27 RHEUMATIC FEVER 627 0.1405
28 MYCOTIC ALLERGY 120 0.1404
29 VITAMIN B1 DECREASED 35 0.1394
30 LUPUS VULGARIS 173 0.1373
31 CAROTID ARTERY THROMBOSIS 114 0.1343
32 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 960 0.1339
33 ATRIAL TACHYCARDIA 279 0.1327
34 PRODUCT MONITORING ERROR 188 0.1301
35 OVERLAP SYNDROME 91 0.1300
36 DUODENAL ULCER PERFORATION 967 0.1299
37 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 36 0.1220
38 DUST ALLERGY 118 0.1203
39 ANTICOAGULANT THERAPY 34 0.1197
40 PRURITUS GENITAL 276 0.1171
41 NEURITIS 178 0.1152
42 MUSCLE INJURY 907 0.1094
43 ONYCHOMYCOSIS 474 0.1079
44 FOLLICULITIS 1119 0.1066
45 ANALGESIC THERAPY 32 0.0997
46 NAIL DISORDER 867 0.0990
47 HELICOBACTER INFECTION 987 0.0959
48 HYPERCHOLESTEROLAEMIA 921 0.0953
49 CONJUNCTIVITIS ALLERGIC 140 0.0945
50 DRUG THERAPY 32 0.0944
51 LIP DRY 853 0.0938
52 BURSITIS 1132 0.0932
53 FINGER DEFORMITY 450 0.0928
54 DISLOCATION OF VERTEBRA 211 0.0924
55 UROGENITAL HAEMORRHAGE 34 0.0912
56 WOUND INFECTION 992 0.0905
57 ADJUSTMENT DISORDER 117 0.0900
58 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 50 0.0891
59 LIVE BIRTH 729 0.0871
60 PEMPHIGUS 1083 0.0865
61 INFUSION SITE REACTION 256 0.0856
62 C-REACTIVE PROTEIN 79 0.0852
63 RESPIRATORY SYMPTOM 240 0.0843
64 DEEP VEIN THROMBOSIS POSTOPERATIVE 168 0.0839
65 SYSTEMIC INFECTION 139 0.0838
66 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 169 0.0828
67 PERICARDITIS 1358 0.0807
68 C-REACTIVE PROTEIN ABNORMAL 513 0.0799
69 PRODUCT LABEL CONFUSION 463 0.0794
70 CAROTID ARTERY OCCLUSION 283 0.0775
71 BURNS SECOND DEGREE 135 0.0769
72 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 159 0.0767
73 HAND DEFORMITY 996 0.0759
74 RETINITIS 127 0.0735
75 JOINT RANGE OF MOTION DECREASED 971 0.0723
76 BACK INJURY 784 0.0720
77 GRIP STRENGTH DECREASED 624 0.0708
78 X-RAY ABNORMAL 122 0.0682
79 TENSION HEADACHE 289 0.0671
80 SWOLLEN JOINT COUNT INCREASED 207 0.0648
81 SLEEP TERROR 267 0.0633
82 SYNOVITIS 1092 0.0605
83 TOTAL LUNG CAPACITY DECREASED 88 0.0551
84 FORCED EXPIRATORY VOLUME DECREASED 156 0.0550
85 PORPHYRIA ACUTE 78 0.0544
86 OBESITY 865 0.0542
87 GLOSSODYNIA 1148 0.0512
88 COELIAC DISEASE 502 0.0511
89 BLOOD FOLATE DECREASED 37 0.0509
90 BONE EROSION 166 0.0469
91 IRRITABLE BOWEL SYNDROME 1004 0.0468
92 LUNG OPACITY 121 0.0459
93 VASCULITIS 534 0.0458
94 PERSONALITY DISORDER 120 0.0458
95 NORMOCHROMIC NORMOCYTIC ANAEMIA 137 0.0456
96 TASTE DISORDER 906 0.0446
97 HYPOPNOEA 146 0.0420
98 PULMONARY HYPOPLASIA 33 0.0419
99 BRONCHIECTASIS 279 0.0414
100 WOUND 1148 0.0410
101 FIBROMYALGIA 983 0.0404
102 OBSTRUCTIVE AIRWAYS DISORDER 449 0.0403
103 LIVER FUNCTION TEST INCREASED 816 0.0380
104 BLOOD PRESSURE SYSTOLIC ABNORMAL 90 0.0364
105 TYPE 2 DIABETES MELLITUS 1216 0.0361
106 PLEURITIC PAIN 99 0.0358
107 SYSTEMIC LUPUS ERYTHEMATOSUS 1252 0.0352
108 PULPITIS DENTAL 33 0.0350
109 NEUROLOGICAL SYMPTOM 198 0.0346
110 FACIAL PAIN 309 0.0346
111 OBSTRUCTIVE SLEEP APNOEA SYNDROME 50 0.0343
112 LIVER INJURY 837 0.0341
113 PULMONARY ALVEOLAR HAEMORRHAGE 190 0.0338
114 CONTRAINDICATED PRODUCT ADMINISTERED 1021 0.0337
115 SUBARACHNOID HAEMORRHAGE 337 0.0331
116 EPILEPSY 1005 0.0328
117 RENAL ARTERY STENOSIS 45 0.0326
118 ADVERSE REACTION 424 0.0319
119 OSTEOCHONDROSIS 37 0.0319
120 C-REACTIVE PROTEIN INCREASED 1139 0.0313
121 IMPAIRED HEALING 1020 0.0310
122 SERONEGATIVE ARTHRITIS 35 0.0305
123 CONGENITAL ANOMALY 236 0.0305
124 ALCOHOL POISONING 80 0.0298
125 AORTIC DILATATION 33 0.0297
126 RHEUMATOID FACTOR POSITIVE 171 0.0296
127 CAROTID ARTERIOSCLEROSIS 30 0.0291
128 NORMAL NEWBORN 158 0.0290
129 PULMONARY FIBROSIS 550 0.0286
130 LYMPHOCYTE COUNT ABNORMAL 32 0.0284
131 NIGHT SWEATS 916 0.0284
132 PSORIATIC ARTHROPATHY 1131 0.0278
133 CHRONIC SPONTANEOUS URTICARIA 32 0.0276
134 ARTERIOSCLEROSIS CORONARY ARTERY 178 0.0268
135 OSTEOARTHRITIS 1130 0.0266
136 WHEEZING 1561 0.0263
137 LOWER RESPIRATORY TRACT INFECTION 1182 0.0260
138 GAIT INABILITY 859 0.0257
139 RALES 148 0.0255
140 LUNG DISORDER 1240 0.0253
141 AUTOIMMUNE DISORDER 236 0.0242
142 ULCER HAEMORRHAGE 163 0.0241
143 BLOOD PRESSURE DIASTOLIC ABNORMAL 61 0.0240
144 ACTINIC KERATOSIS 61 0.0235
145 FULL BLOOD COUNT ABNORMAL 248 0.0234
146 BLOOD CHOLESTEROL INCREASED 1084 0.0232
147 DRUG TOLERANCE DECREASED 64 0.0228
148 INFLAMMATION 1173 0.0227
149 RHINITIS 177 0.0219
150 EXOSTOSIS 200 0.0219
151 GENERAL PHYSICAL HEALTH DETERIORATION 2500 0.0216
152 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 36 0.0216
153 SPUTUM DISCOLOURED 201 0.0212
154 GANGRENE 127 0.0211
155 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 184 0.0208
156 MUSCULOSKELETAL PAIN 1075 0.0205
157 VENTRICULAR TACHYCARDIA 337 0.0204
158 DIASTOLIC DYSFUNCTION 62 0.0201
159 ANOSMIA 290 0.0200
160 BLISTER 1121 0.0199
161 BENIGN PROSTATIC HYPERPLASIA 101 0.0195
162 ARTERIOSCLEROSIS 184 0.0195
163 HEPATITIS 500 0.0195
164 HYPERPHOSPHATAEMIA 42 0.0195
165 INTENTIONAL PRODUCT USE ISSUE 1710 0.0195
166 FEAR OF DISEASE 34 0.0191
167 DRUG-INDUCED LIVER INJURY 599 0.0191
168 ARTHROPATHY 1057 0.0190
169 HEMIPLEGIA 158 0.0190
170 ASPIRATION 208 0.0190
171 GINGIVAL PAIN 150 0.0188
172 DRUG TOLERANCE 94 0.0186
173 INFUSION RELATED REACTION 1228 0.0185
174 BREAST CANCER STAGE II 154 0.0185
175 ARTERIAL OCCLUSIVE DISEASE 145 0.0184
176 LICHENOID KERATOSIS 42 0.0184
177 CORONARY ARTERY STENOSIS 92 0.0183
178 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 310 0.0182
179 PAROSMIA 136 0.0180
180 GASTROOESOPHAGEAL REFLUX DISEASE 1444 0.0179
181 RED BLOOD CELL SEDIMENTATION RATE INCREASED 197 0.0178
182 OLIGOHYDRAMNIOS 59 0.0177
183 URINARY HESITATION 42 0.0176
184 PARESIS 39 0.0175
185 MATERNAL EXPOSURE TIMING UNSPECIFIED 65 0.0173
186 PARADOXICAL DRUG REACTION 63 0.0171
187 CARDIAC MURMUR 148 0.0171
188 MIGRAINE 1599 0.0167
189 PAINFUL RESPIRATION 40 0.0166
190 HYPERTENSIVE HEART DISEASE 31 0.0166
191 THERAPEUTIC PRODUCT EFFECT DECREASED 741 0.0165
192 CHRONIC GASTRITIS 37 0.0164
193 STOMATITIS 991 0.0163
194 SENSORY LOSS 128 0.0159
195 PRESCRIBED OVERDOSE 307 0.0158
196 NECK PAIN 879 0.0157
197 POLYP 102 0.0156
198 DIVERTICULUM INTESTINAL HAEMORRHAGIC 35 0.0156
199 BLOOD LOSS ANAEMIA 35 0.0154
200 HEPATIC ENZYME INCREASED 1044 0.0153
201 ELECTROCARDIOGRAM ABNORMAL 120 0.0153
202 AORTIC VALVE INCOMPETENCE 65 0.0153
203 CHOLESTATIC LIVER INJURY 34 0.0153
204 BLOOD PRESSURE SYSTOLIC INCREASED 297 0.0152
205 SLEEP DISORDER 1072 0.0152
206 IMMOBILE 66 0.0151
207 HYPERKINESIA 32 0.0151
208 SPINAL OSTEOARTHRITIS 132 0.0150
209 TROPONIN INCREASED 114 0.0150
210 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 255 0.0149
211 PUSTULAR PSORIASIS 51 0.0148
212 LOWER LIMB FRACTURE 285 0.0148
213 MOTOR DYSFUNCTION 151 0.0148
214 AORTIC ARTERIOSCLEROSIS 38 0.0148
215 DRY MOUTH 1191 0.0147
216 BLOOD CALCIUM INCREASED 128 0.0146
217 HYPERLACTACIDAEMIA 39 0.0145
218 MUSCLE TWITCHING 334 0.0145
219 PRESCRIBED UNDERDOSE 289 0.0145
220 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 59 0.0144
221 DEREALISATION 31 0.0144
222 ATRIOVENTRICULAR BLOCK SECOND DEGREE 43 0.0142
223 AFFECT LABILITY 136 0.0141
224 SNORING 53 0.0140
225 HAEMOPTYSIS 390 0.0140
226 DRUG INTOLERANCE 1348 0.0139
227 CARDIAC FAILURE CHRONIC 59 0.0138
228 MATERNAL EXPOSURE DURING PREGNANCY 1233 0.0138
229 DYSPNOEA AT REST 40 0.0138
230 ANGINA PECTORIS 395 0.0138
231 MOBILITY DECREASED 985 0.0137
232 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 69 0.0136
233 DIPLOPIA 353 0.0136
234 FREQUENT BOWEL MOVEMENTS 363 0.0134
235 TRANSIENT ISCHAEMIC ATTACK 453 0.0134
236 LICHEN PLANUS 31 0.0134
237 MUSCLE SPASTICITY 164 0.0133
238 HEMIPARESIS 226 0.0133
239 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 640 0.0133
240 HYPERTENSIVE CRISIS 148 0.0133
241 SWELLING 1244 0.0133
242 TINNITUS 609 0.0132
243 RED CELL DISTRIBUTION WIDTH INCREASED 55 0.0132
244 MUSCULAR WEAKNESS 1497 0.0132
245 ANURIA 113 0.0131
246 IRON DEFICIENCY 59 0.0131
247 PRODUCT PRESCRIBING ERROR 310 0.0130
248 LEFT VENTRICULAR DYSFUNCTION 86 0.0128
249 SCIATICA 204 0.0128
250 LUPUS-LIKE SYNDROME 116 0.0128
251 SKIN HAEMORRHAGE 189 0.0127
252 DUODENITIS 39 0.0127
253 LIP SWELLING 420 0.0126
254 HAEMATOCHEZIA 691 0.0125
255 SUPRAVENTRICULAR EXTRASYSTOLES 42 0.0124
256 WALKING AID USER 81 0.0123
257 ADRENAL INSUFFICIENCY 149 0.0123
258 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 79 0.0122
259 RHEUMATOID ARTHRITIS 1378 0.0121
260 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 853 0.0120
261 TUBULOINTERSTITIAL NEPHRITIS 224 0.0119
262 HYPOMAGNESAEMIA 166 0.0119
263 PAIN OF SKIN 320 0.0119
264 HYPONATRAEMIA 666 0.0118
265 SINUS CONGESTION 158 0.0117
266 THERAPEUTIC REACTION TIME DECREASED 34 0.0116
267 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 119 0.0116
268 BREATH SOUNDS ABNORMAL 57 0.0115
269 CONFUSIONAL STATE 1860 0.0115
270 EAR PAIN 222 0.0114
271 ELECTROLYTE IMBALANCE 131 0.0113
272 NODULE 147 0.0113
273 HYPERKALAEMIA 395 0.0113
274 IMPAIRED QUALITY OF LIFE 161 0.0112
275 INFLAMMATORY MARKER INCREASED 55 0.0111
276 HYPOVENTILATION 36 0.0110
277 PERIPHERAL SWELLING 1691 0.0110
278 LARGE INTESTINE POLYP 76 0.0110
279 JOINT SWELLING 1318 0.0109
280 AORTIC STENOSIS 38 0.0109
281 SPINAL STENOSIS 45 0.0109
282 MUSCULOSKELETAL STIFFNESS 949 0.0108
283 BLOOD TEST ABNORMAL 152 0.0108
284 EXPOSURE DURING PREGNANCY 669 0.0108
285 ATRIOVENTRICULAR BLOCK COMPLETE 72 0.0107
286 DYSPEPSIA 1056 0.0107
287 GASTRITIS EROSIVE 50 0.0107
288 RESPIRATORY TRACT CONGESTION 170 0.0107
289 BLOOD PRESSURE FLUCTUATION 256 0.0107
290 HYPERTENSION 2255 0.0106
291 SUSPECTED OFF LABEL USE 48 0.0106
292 IDIOPATHIC PULMONARY FIBROSIS 42 0.0106
293 TRICUSPID VALVE INCOMPETENCE 84 0.0106
294 ERYSIPELAS 53 0.0105
295 INJURY 740 0.0105
296 HIGH DENSITY LIPOPROTEIN DECREASED 35 0.0105
297 ABDOMINAL DISCOMFORT 1757 0.0105
298 ARTERIOSPASM CORONARY 42 0.0105
299 SPONDYLITIS 38 0.0104
300 VITAMIN B12 DECREASED 30 0.0104
301 TREATMENT FAILURE 862 0.0104
302 ACUTE KIDNEY INJURY 1592 0.0104
303 CEREBRAL ISCHAEMIA 53 0.0103
304 DIVERTICULUM INTESTINAL 45 0.0103
305 LEFT VENTRICULAR HYPERTROPHY 44 0.0103
306 HYPOVOLAEMIA 60 0.0102
307 EXERCISE TOLERANCE DECREASED 59 0.0102
308 POLYARTHRITIS 54 0.0102
309 MEMORY IMPAIRMENT 1405 0.0102
310 RASH VESICULAR 49 0.0101
311 ILL-DEFINED DISORDER 613 0.0101
312 HYPERURICAEMIA 41 0.0100
313 ANGIOEDEMA 441 0.0100
314 BLOOD PRESSURE DIASTOLIC DECREASED 73 0.0099
315 RASH PAPULAR 221 0.0099
316 CHRONIC SINUSITIS 37 0.0098
317 GASTROINTESTINAL DISORDER 881 0.0098
318 HYPOXIA 344 0.0098
319 EYE PRURITUS 328 0.0098
320 COORDINATION ABNORMAL 135 0.0097
321 ACUTE CORONARY SYNDROME 80 0.0096
322 BODY TEMPERATURE DECREASED 95 0.0096
323 MYOSITIS 86 0.0096
324 DISTURBANCE IN ATTENTION 516 0.0096
325 BLOOD PRESSURE DIASTOLIC INCREASED 44 0.0095
326 GOITRE 39 0.0095
327 RECTAL HAEMORRHAGE 408 0.0095
328 PEMPHIGOID 71 0.0094
329 HYPOAESTHESIA 1408 0.0094
330 BRADYCARDIA 496 0.0093
331 GLOMERULAR FILTRATION RATE DECREASED 114 0.0093
332 LOSS OF CONTROL OF LEGS 35 0.0092
333 HYPOTHYROIDISM 294 0.0092
334 ORTHOSTATIC HYPOTENSION 160 0.0092
335 LUMBAR VERTEBRAL FRACTURE 42 0.0092
336 DELIRIUM 317 0.0091
337 TRANSAMINASES INCREASED 203 0.0091
338 PRODUCTIVE COUGH 434 0.0091
339 HYPOPHOSPHATAEMIA 67 0.0091
340 LEFT VENTRICULAR FAILURE 31 0.0090
341 ABDOMINAL PAIN UPPER 1846 0.0090
342 INGUINAL HERNIA 54 0.0089
343 LACTIC ACIDOSIS 287 0.0089
344 CARDIAC FAILURE ACUTE 59 0.0088
345 BLOOD URIC ACID INCREASED 51 0.0088
346 DYSPNOEA EXERTIONAL 331 0.0088
347 PALPITATIONS 1019 0.0087
348 ATRIOVENTRICULAR BLOCK 67 0.0087
349 PROSTATOMEGALY 34 0.0086
350 ASTHMA 975 0.0086
351 HEPATIC CIRRHOSIS 162 0.0086
352 NEUTROPHIL COUNT INCREASED 88 0.0086
353 PULMONARY MASS 128 0.0086
354 SPINAL PAIN 100 0.0085
355 UROSEPSIS 78 0.0084
356 IRON DEFICIENCY ANAEMIA 78 0.0084
357 GLOSSITIS 30 0.0084
358 NOCTURIA 102 0.0084
359 PARAESTHESIA 1316 0.0084
360 APHASIA 252 0.0083
361 POLYURIA 68 0.0083
362 AMNESIA 539 0.0083
363 TACHYCARDIA 731 0.0082
364 CYSTITIS 261 0.0082
365 DISCOMFORT 500 0.0082
366 ABDOMINAL DISTENSION 850 0.0081
367 COGNITIVE DISORDER 380 0.0081
368 MITRAL VALVE INCOMPETENCE 92 0.0081
369 OEDEMA 440 0.0081
370 BLINDNESS 330 0.0081
371 NASOPHARYNGITIS 1490 0.0081
372 NIGHTMARE 277 0.0080
373 IMPAIRED WORK ABILITY 171 0.0080
374 CIRCULATORY COLLAPSE 136 0.0080
375 RENAL FUNCTION TEST ABNORMAL 37 0.0080
376 FOOT DEFORMITY 88 0.0079
377 UPPER GASTROINTESTINAL HAEMORRHAGE 133 0.0079
378 MEDICATION ERROR 436 0.0078
379 EATING DISORDER 167 0.0078
380 HAEMORRHOIDS 152 0.0078
381 HYPOKALAEMIA 359 0.0078
382 SINUS DISORDER 154 0.0078
383 MYOPATHY 67 0.0077
384 HYPERTHYROIDISM 112 0.0077
385 HEPATIC STEATOSIS 144 0.0077
386 BLOOD CREATININE INCREASED 503 0.0077
387 HYPERLIPIDAEMIA 92 0.0077
388 OEDEMA PERIPHERAL 936 0.0077
389 BUNDLE BRANCH BLOCK RIGHT 35 0.0076
390 JOINT DISLOCATION 80 0.0076
391 RENAL CYST 60 0.0075
392 MUSCLE SPASMS 1384 0.0075
393 ACUTE MYOCARDIAL INFARCTION 222 0.0075
394 HIATUS HERNIA 97 0.0075
395 BLOOD PRESSURE SYSTOLIC DECREASED 34 0.0075
396 PRESYNCOPE 181 0.0074
397 DYSARTHRIA 276 0.0073
398 SNEEZING 164 0.0073
399 BUNDLE BRANCH BLOCK LEFT 31 0.0073
400 POLYNEUROPATHY 87 0.0073
401 RENAL IMPAIRMENT 610 0.0073
402 VERTIGO 440 0.0072
403 BASAL CELL CARCINOMA 112 0.0072
404 SWOLLEN TONGUE 224 0.0072
405 ALOPECIA 1406 0.0072
406 GOUT 128 0.0071
407 AORTIC ANEURYSM 54 0.0071
408 CONDITION AGGRAVATED 2156 0.0071
409 GINGIVITIS 38 0.0070
410 COLITIS ULCERATIVE 314 0.0070
411 HEART RATE DECREASED 246 0.0070
412 HAEMORRHOIDAL HAEMORRHAGE 34 0.0070
413 DUODENAL ULCER 49 0.0069
414 MYASTHENIA GRAVIS 56 0.0069
415 ATRIAL FIBRILLATION 673 0.0069
416 PULMONARY CONGESTION 91 0.0069
417 URINARY TRACT DISORDER 31 0.0069
418 HAEMATOMA 178 0.0069
419 PERFORMANCE STATUS DECREASED 32 0.0069
420 GASTROENTERITIS 100 0.0068
421 PROTEIN URINE PRESENT 34 0.0068
422 HEART RATE INCREASED 675 0.0068
423 GAMMA-GLUTAMYLTRANSFERASE INCREASED 150 0.0068
424 MICTURITION URGENCY 77 0.0067
425 VENTRICULAR EXTRASYSTOLES 69 0.0066
426 HYPOCALCAEMIA 125 0.0066
427 CORONARY ARTERY DISEASE 200 0.0066
428 BLOOD PRESSURE ABNORMAL 131 0.0066
429 LIPASE INCREASED 50 0.0065
430 DEPRESSION 1483 0.0065
431 HAEMATOCRIT DECREASED 129 0.0065
432 INJECTION SITE REACTION 445 0.0065
433 INTRACRANIAL PRESSURE INCREASED 36 0.0065
434 SCOLIOSIS 40 0.0065
435 ANEURYSM 32 0.0064
436 SINUS BRADYCARDIA 62 0.0064
437 BLOOD PRESSURE INCREASED 979 0.0064
438 SYNCOPE 633 0.0063
439 ABNORMAL LOSS OF WEIGHT 43 0.0063
440 URTICARIA 1056 0.0063
441 DYSLIPIDAEMIA 32 0.0063
442 ORGANISING PNEUMONIA 31 0.0062
443 ABDOMINAL PAIN LOWER 158 0.0062
444 CHEST PAIN 1154 0.0062
445 WEIGHT INCREASED 1393 0.0062
446 FLUID INTAKE REDUCED 31 0.0062
447 INCORRECT PRODUCT ADMINISTRATION DURATION 134 0.0062
448 URINARY RETENTION 206 0.0062
449 GASTRITIS 162 0.0062
450 BLOOD IRON DECREASED 73 0.0061
451 ASTHENIA 2309 0.0061
452 PNEUMONIA 1986 0.0061
453 CHOLECYSTITIS 73 0.0061
454 NEPHROTIC SYNDROME 42 0.0061
455 ARTHRITIS 481 0.0061
456 PULMONARY EMBOLISM 581 0.0061
457 HYPOTENSION 1225 0.0061
458 TACHYPNOEA 83 0.0061
459 JOINT STIFFNESS 160 0.0061
460 DYSPNOEA 3448 0.0061
461 DIZZINESS 3030 0.0061
462 DIVERTICULUM 43 0.0060
463 PROTEINURIA 115 0.0060
464 FEMORAL NECK FRACTURE 31 0.0060
465 CARDIAC FAILURE 483 0.0060
466 ARTHRALGIA 2487 0.0060
467 ANAEMIA 1139 0.0060
468 ANAL FISSURE 32 0.0060
469 PAIN IN EXTREMITY 1756 0.0060
470 LOWER GASTROINTESTINAL HAEMORRHAGE 44 0.0059
471 HEAD DISCOMFORT 105 0.0059
472 PALLOR 161 0.0059
473 FAECES SOFT 43 0.0059
474 RESPIRATORY DISORDER 176 0.0059
475 ORAL DISORDER 43 0.0059
476 PRODUCT QUALITY ISSUE 790 0.0058
477 TENDON PAIN 44 0.0058
478 ACCIDENTAL OVERDOSE 212 0.0058
479 PRODUCT USE IN UNAPPROVED INDICATION 1436 0.0058
480 FALL 1928 0.0058
481 ATRIAL FLUTTER 46 0.0058
482 MELAENA 126 0.0057
483 DEHYDRATION 757 0.0057
484 APHTHOUS ULCER 44 0.0057
485 ARRHYTHMIA 267 0.0056
486 GASTROINTESTINAL INFLAMMATION 44 0.0056
487 CORONAVIRUS INFECTION 37 0.0056
488 TENDON RUPTURE 69 0.0056
489 PYREXIA 1933 0.0056
490 ON AND OFF PHENOMENON 31 0.0056
491 DRUG INTERACTION 885 0.0056
492 COUGH 1547 0.0055
493 VOMITING 2582 0.0055
494 ENTERITIS 35 0.0055
495 ULCER 87 0.0055
496 PARKINSONISM 53 0.0054
497 HALLUCINATION 409 0.0054
498 DEFAECATION URGENCY 38 0.0054
499 ABDOMINAL PAIN 1260 0.0054
500 LIVER DISORDER 240 0.0054
501 BLOOD COUNT ABNORMAL 82 0.0054
502 UPPER RESPIRATORY TRACT INFECTION 249 0.0054
503 CONTUSION 517 0.0054
504 DECREASED APPETITE 1245 0.0054
505 WEIGHT FLUCTUATION 56 0.0053
506 ELECTROCARDIOGRAM QT PROLONGED 192 0.0053
507 MAJOR DEPRESSION 39 0.0053
508 MYOCARDITIS 61 0.0053
509 BLOOD PRESSURE INADEQUATELY CONTROLLED 32 0.0053
510 CHEST DISCOMFORT 544 0.0053
511 VISUAL IMPAIRMENT 657 0.0053
512 HAEMATURIA 179 0.0052
513 DYSURIA 192 0.0052
514 HYPOGLYCAEMIA 251 0.0052
515 ECZEMA 270 0.0052
516 SHOCK HAEMORRHAGIC 42 0.0052
517 OLIGURIA 32 0.0051
518 BLINDNESS TRANSIENT 38 0.0051
519 BLOOD CREATINE PHOSPHOKINASE INCREASED 148 0.0051
520 THERAPY NON-RESPONDER 231 0.0051
521 PLATELET COUNT INCREASED 67 0.0051
522 HAEMODYNAMIC INSTABILITY 39 0.0051
523 INSOMNIA 1362 0.0051
524 BLOOD URINE PRESENT 97 0.0051
525 URINE ODOUR ABNORMAL 30 0.0051
526 ERECTILE DYSFUNCTION 131 0.0051
527 ANGINA UNSTABLE 33 0.0051
528 CEREBRAL INFARCTION 124 0.0051
529 CHROMATURIA 114 0.0050
530 PLEURAL EFFUSION 307 0.0050
531 MALAISE 2212 0.0050
532 NEUTROPENIC SEPSIS 36 0.0050
533 HYPERHIDROSIS 649 0.0050
534 CONCOMITANT DISEASE AGGRAVATED 31 0.0050
535 EOSINOPHILIA 88 0.0050
536 EJECTION FRACTION DECREASED 78 0.0050
537 PROTHROMBIN TIME PROLONGED 30 0.0050
538 GROIN PAIN 44 0.0050
539 HAEMATEMESIS 127 0.0050
540 OSTEOPOROSIS 206 0.0050
541 METABOLIC ACIDOSIS 160 0.0050
542 UNDERDOSE 364 0.0050
543 RHABDOMYOLYSIS 207 0.0050
544 PYELONEPHRITIS 43 0.0050
545 CARDIOMEGALY 61 0.0050
546 ROAD TRAFFIC ACCIDENT 207 0.0049
547 PANCREATITIS ACUTE 111 0.0049
548 SLEEP APNOEA SYNDROME 94 0.0049
549 HEPATITIS ACUTE 32 0.0049
550 DIABETES MELLITUS INADEQUATE CONTROL 87 0.0049
551 PNEUMOCYSTIS JIROVECII PNEUMONIA 49 0.0049
552 COVID-19 856 0.0049
553 DIARRHOEA 3140 0.0049
554 ADVERSE DRUG REACTION 436 0.0048
555 NEURALGIA 118 0.0048
556 INTENTIONAL PRODUCT MISUSE 424 0.0048
557 SEROTONIN SYNDROME 93 0.0048
558 JAUNDICE 130 0.0048
559 HYPOKINESIA 70 0.0048
560 HYPERSENSITIVITY 894 0.0048
561 NEPHROPATHY TOXIC 54 0.0048
562 COLITIS 181 0.0048
563 COLD SWEAT 84 0.0048
564 POOR VENOUS ACCESS 49 0.0047
565 DISORIENTATION 186 0.0047
566 BLOOD THYROID STIMULATING HORMONE INCREASED 43 0.0047
567 FAECES DISCOLOURED 101 0.0047
568 BRAIN FOG 73 0.0047
569 SPINAL DISORDER 44 0.0046
570 ACUTE RESPIRATORY DISTRESS SYNDROME 82 0.0046
571 WEIGHT DECREASED 1290 0.0046
572 RESTLESSNESS 169 0.0046
573 INTERSTITIAL LUNG DISEASE 222 0.0046
574 HEADACHE 2867 0.0046
575 MYALGIA 776 0.0046
576 KETOACIDOSIS 34 0.0045
577 SUBDURAL HAEMATOMA 65 0.0045
578 HAEMOLYSIS 35 0.0045
579 PAIN 2778 0.0045
580 CATARACT 269 0.0045
581 ABNORMAL FAECES 37 0.0045
582 HYPOPHAGIA 115 0.0045
583 FATIGUE 3502 0.0045
584 MYOCARDIAL ISCHAEMIA 51 0.0045
585 SINUSITIS 458 0.0045
586 MUCOSAL INFLAMMATION 117 0.0045
587 AUTOIMMUNE HEPATITIS 31 0.0045
588 OFF LABEL USE 3899 0.0044
589 BLOOD CALCIUM DECREASED 50 0.0044
590 HYPERGLYCAEMIA 162 0.0044
591 EXTRASYSTOLES 31 0.0044
592 HIP ARTHROPLASTY 68 0.0044
593 FEBRILE NEUTROPENIA 294 0.0044
594 OXYGEN SATURATION DECREASED 249 0.0044
595 POST PROCEDURAL INFECTION 36 0.0044
596 LYMPHOPENIA 62 0.0044
597 PRODUCT USE ISSUE 823 0.0044
598 MULTIPLE ORGAN DYSFUNCTION SYNDROME 124 0.0044
599 SKIN LESION 120 0.0044
600 RASH 1907 0.0044
601 PHARYNGITIS 54 0.0043
602 HEPATOCELLULAR CARCINOMA 33 0.0043
603 RIB FRACTURE 89 0.0043
604 APATHY 63 0.0043
605 ANXIETY 1228 0.0043
606 PETECHIAE 45 0.0043
607 WHITE BLOOD CELL COUNT INCREASED 165 0.0043
608 CHOLELITHIASIS 141 0.0043
609 PERIPHERAL COLDNESS 59 0.0043
610 SUPRAVENTRICULAR TACHYCARDIA 41 0.0043
611 TENDONITIS 66 0.0043
612 MUSCULOSKELETAL DISCOMFORT 73 0.0042
613 COVID-19 PNEUMONIA 50 0.0042
614 CORONARY ARTERY OCCLUSION 58 0.0042
615 DIZZINESS POSTURAL 41 0.0042
616 MUSCULOSKELETAL CHEST PAIN 65 0.0042
617 FLATULENCE 238 0.0042
618 BACK PAIN 973 0.0042
619 KNEE ARTHROPLASTY 88 0.0042
620 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 218 0.0042
621 IMMUNODEFICIENCY 62 0.0042
622 SINUS TACHYCARDIA 59 0.0042
623 DISABILITY 82 0.0041
624 INTERNATIONAL NORMALISED RATIO INCREASED 118 0.0041
625 SKIN LACERATION 45 0.0041
626 GENERAL SYMPTOM 31 0.0041
627 NAUSEA 3267 0.0041
628 RESTLESS LEGS SYNDROME 75 0.0041
629 BACK DISORDER 67 0.0041
630 DYSPHAGIA 391 0.0041
631 NERVE COMPRESSION 38 0.0041
632 INTERNAL HAEMORRHAGE 47 0.0041
633 CEREBRAL HAEMORRHAGE 147 0.0041
634 QUALITY OF LIFE DECREASED 55 0.0041
635 EYE INFLAMMATION 39 0.0041
636 RHINORRHOEA 264 0.0041
637 URINARY INCONTINENCE 121 0.0041
638 LUNG INFILTRATION 36 0.0041
639 BLOOD POTASSIUM INCREASED 66 0.0041
640 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 223 0.0041
641 RENAL PAIN 43 0.0041
642 RESPIRATORY RATE INCREASED 36 0.0041
643 HYPERCALCAEMIA 50 0.0040
644 DRUG LEVEL INCREASED 67 0.0040
645 SQUAMOUS CELL CARCINOMA 38 0.0040
646 ATELECTASIS 39 0.0040
647 DEPRESSED LEVEL OF CONSCIOUSNESS 159 0.0040
648 MIDDLE INSOMNIA 75 0.0040
649 FRACTURE 76 0.0040
650 BRAIN INJURY 40 0.0040
651 BLOOD PRESSURE DECREASED 265 0.0040
652 BLOOD SODIUM DECREASED 75 0.0040
653 LEUKOCYTOSIS 72 0.0040
654 LEUKOPENIA 199 0.0040
655 CARDIOGENIC SHOCK 57 0.0040
656 EOSINOPHIL COUNT INCREASED 33 0.0040
657 OESOPHAGITIS 43 0.0039
658 INTERVERTEBRAL DISC PROTRUSION 86 0.0039
659 DIVERTICULITIS 109 0.0039
660 BRONCHOSPASM 56 0.0039
661 BLOOD LACTATE DEHYDROGENASE INCREASED 62 0.0039
662 FOETAL EXPOSURE DURING PREGNANCY 318 0.0039
663 BLOOD ALBUMIN DECREASED 31 0.0039
664 INTERVERTEBRAL DISC DEGENERATION 36 0.0039
665 VENTRICULAR FIBRILLATION 43 0.0039
666 FACIAL PARALYSIS 33 0.0039
667 TUMOUR LYSIS SYNDROME 34 0.0039
668 RED BLOOD CELL COUNT DECREASED 110 0.0038
669 LYMPHOCYTE COUNT DECREASED 68 0.0038
670 INFLUENZA 429 0.0038
671 FLANK PAIN 36 0.0038
672 RASH PRURITIC 208 0.0038
673 SECRETION DISCHARGE 48 0.0038
674 TORSADE DE POINTES 30 0.0038
675 FEELING COLD 106 0.0038
676 HAEMOGLOBIN DECREASED 389 0.0038
677 DEEP VEIN THROMBOSIS 246 0.0038
678 TEMPERATURE INTOLERANCE 39 0.0038
679 URINE OUTPUT DECREASED 33 0.0038
680 AGRANULOCYTOSIS 70 0.0038
681 HEPATOMEGALY 37 0.0038
682 MUSCLE RIGIDITY 45 0.0038
683 ISCHAEMIC STROKE 67 0.0038
684 ERYTHEMA MULTIFORME 35 0.0037
685 CHOLESTASIS 72 0.0037
686 PNEUMONITIS 102 0.0037
687 PREGNANCY 75 0.0037
688 DERMATITIS ALLERGIC 47 0.0037
689 END STAGE RENAL DISEASE 68 0.0037
690 FEELING HOT 228 0.0037
691 LIVER FUNCTION TEST ABNORMAL 108 0.0037
692 ATAXIA 44 0.0037
693 BLOOD UREA INCREASED 62 0.0037
694 INFECTION 534 0.0037
695 POOR QUALITY SLEEP 79 0.0037
696 GINGIVAL BLEEDING 50 0.0037
697 CARDIOMYOPATHY 54 0.0037
698 BACTERIAL INFECTION 68 0.0036
699 ASCITES 107 0.0036
700 GASTROINTESTINAL PAIN 40 0.0036
701 VITAMIN D DECREASED 31 0.0036
702 DEPRESSED MOOD 191 0.0036
703 GAIT DISTURBANCE 691 0.0036
704 INCONTINENCE 38 0.0036
705 MYOCARDIAL INFARCTION 624 0.0036
706 GASTROINTESTINAL INFECTION 32 0.0036
707 ORAL CANDIDIASIS 47 0.0036
708 DRUG ERUPTION 63 0.0036
709 LIGAMENT SPRAIN 35 0.0035
710 PHARYNGEAL SWELLING 34 0.0035
711 JOINT INJURY 74 0.0035
712 VITREOUS FLOATERS 34 0.0035
713 EYE INFECTION 39 0.0035
714 THROMBOSIS 276 0.0034
715 POLLAKIURIA 143 0.0034
716 GLAUCOMA 66 0.0034
717 SOMNOLENCE 689 0.0034
718 HALLUCINATION, VISUAL 72 0.0034
719 CEREBROVASCULAR ACCIDENT 571 0.0034
720 RENAL TUBULAR NECROSIS 33 0.0034
721 THIRST 60 0.0034
722 HAEMOLYTIC ANAEMIA 30 0.0033
723 RESPIRATORY TRACT INFECTION 87 0.0033
724 PERSONALITY CHANGE 31 0.0033
725 DIABETIC KETOACIDOSIS 80 0.0033
726 GLYCOSYLATED HAEMOGLOBIN INCREASED 84 0.0033
727 ALTERED STATE OF CONSCIOUSNESS 72 0.0033
728 CONSTIPATION 722 0.0033
729 CARDIOVASCULAR DISORDER 84 0.0033
730 CHILLS 387 0.0033
731 RASH MACULO-PAPULAR 73 0.0033
732 HAEMORRHAGE INTRACRANIAL 49 0.0033
733 EAR INFECTION 87 0.0033
734 DRY SKIN 436 0.0033
735 RETINAL DETACHMENT 30 0.0033
736 GASTRIC ULCER 62 0.0033
737 TOOTHACHE 59 0.0033
738 NASAL CONGESTION 191 0.0032
739 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 585 0.0032
740 ADVERSE EVENT 299 0.0032
741 BRONCHITIS 240 0.0032
742 FLUID RETENTION 164 0.0032
743 PRODUCT ADMINISTRATION ERROR 65 0.0032
744 OROPHARYNGEAL PAIN 297 0.0032
745 RENAL FAILURE ACUTE 136 0.0032
746 FISTULA 36 0.0032
747 TREMOR 530 0.0032
748 HEPATIC FUNCTION ABNORMAL 119 0.0032
749 THROMBOCYTOPENIA 356 0.0032
750 INFLUENZA LIKE ILLNESS 262 0.0032
751 SENSORY DISTURBANCE 51 0.0032
752 ERUCTATION 61 0.0031
753 PANCREATITIS 166 0.0031
754 NEPHROLITHIASIS 144 0.0031
755 RENAL FAILURE 416 0.0031
756 HERPES ZOSTER 180 0.0031
757 PSORIASIS 409 0.0031
758 PANCYTOPENIA 175 0.0031
759 DIABETES MELLITUS 237 0.0031
760 HYPOTONIA 31 0.0031
761 ACCIDENT 37 0.0031
762 LETHARGY 177 0.0031
763 CELLULITIS 155 0.0031
764 LIMB DISCOMFORT 95 0.0031
765 SKIN ULCER 79 0.0031
766 TRANSFUSION 32 0.0031
767 DYSGEUSIA 226 0.0030
768 GASTROINTESTINAL HAEMORRHAGE 254 0.0030
769 PNEUMOTHORAX 48 0.0030
770 HALLUCINATION, AUDITORY 48 0.0030
771 PULMONARY OEDEMA 135 0.0030
772 URINARY TRACT INFECTION 513 0.0030
773 PRURITUS 1150 0.0030
774 PERICARDIAL EFFUSION 69 0.0030
775 PARAESTHESIA ORAL 43 0.0030
776 SWELLING FACE 192 0.0029
777 EPISTAXIS 220 0.0029
778 EXTRAPYRAMIDAL DISORDER 73 0.0029
779 SKIN EXFOLIATION 248 0.0029
780 APHONIA 41 0.0029
781 SEPSIS 327 0.0029
782 ALANINE AMINOTRANSFERASE INCREASED 179 0.0029
783 LACRIMATION INCREASED 88 0.0029
784 PHOTOSENSITIVITY REACTION 48 0.0029
785 LOSS OF CONSCIOUSNESS 372 0.0029
786 TOXIC EPIDERMAL NECROLYSIS 44 0.0029
787 MYOCLONUS 34 0.0028
788 DISSEMINATED INTRAVASCULAR COAGULATION 40 0.0028
789 ILEUS 35 0.0028
790 AGEUSIA 70 0.0028
791 BODY TEMPERATURE INCREASED 57 0.0028
792 BLOOD GLUCOSE INCREASED 522 0.0028
793 SEASONAL ALLERGY 39 0.0028
794 HEPATIC FAILURE 83 0.0028
795 BURNING SENSATION 193 0.0027
796 CLOSTRIDIUM DIFFICILE INFECTION 60 0.0027
797 DYSSTASIA 80 0.0027
798 ASPARTATE AMINOTRANSFERASE INCREASED 145 0.0027
799 LYMPHADENOPATHY 96 0.0027
800 PHOTOPHOBIA 51 0.0027
801 ABSCESS 43 0.0027
802 GENERALISED TONIC-CLONIC SEIZURE 44 0.0027
803 HEART RATE IRREGULAR 60 0.0027
804 TOOTH INFECTION 35 0.0027
805 FEELING ABNORMAL 636 0.0027
806 SPLENOMEGALY 31 0.0026
807 PNEUMONIA ASPIRATION 66 0.0026
808 SCAR 45 0.0026
809 SEPTIC SHOCK 114 0.0026
810 BALANCE DISORDER 224 0.0026
811 GENERALISED OEDEMA 32 0.0026
812 DELUSION 40 0.0026
813 SKIN REACTION 36 0.0026
814 THROAT IRRITATION 114 0.0025
815 BRAIN OEDEMA 32 0.0025
816 HEAD INJURY 80 0.0025
817 ABNORMAL WEIGHT GAIN 31 0.0025
818 OSTEOPENIA 38 0.0025
819 METASTASES TO LIVER 44 0.0025
820 RESPIRATORY DISTRESS 69 0.0025
821 POST PROCEDURAL COMPLICATION 48 0.0025
822 SARS-COV-2 TEST POSITIVE 33 0.0025
823 BLOOD POTASSIUM DECREASED 74 0.0025
824 SUICIDAL IDEATION 225 0.0025
825 HYPOAESTHESIA ORAL 37 0.0025
826 PULMONARY HYPERTENSION 51 0.0024
827 MUSCLE ATROPHY 31 0.0024
828 BEDRIDDEN 32 0.0024
829 STEVENS-JOHNSON SYNDROME 54 0.0024
830 BONE PAIN 142 0.0024
831 DEVICE RELATED INFECTION 37 0.0024
832 HEPATOCELLULAR INJURY 34 0.0024
833 OSTEONECROSIS OF JAW 59 0.0024
834 HEPATOTOXICITY 53 0.0024
835 HERNIA 46 0.0024
836 ANAPHYLACTIC REACTION 131 0.0024
837 BLOOD BILIRUBIN INCREASED 64 0.0024
838 INTESTINAL OBSTRUCTION 89 0.0024
839 CYANOSIS 37 0.0024
840 ACUTE RESPIRATORY FAILURE 45 0.0023
841 ROTATOR CUFF SYNDROME 30 0.0023
842 BLOOD ALKALINE PHOSPHATASE INCREASED 58 0.0023
843 RESPIRATORY FAILURE 170 0.0023
844 CARPAL TUNNEL SYNDROME 32 0.0023
845 SKIN DISORDER 76 0.0023
846 BLINDNESS UNILATERAL 32 0.0023
847 RENAL DISORDER 105 0.0023
848 PLATELET COUNT DECREASED 240 0.0022
849 MALIGNANT NEOPLASM PROGRESSION 230 0.0022
850 LIMB INJURY 61 0.0022
851 CYTOKINE RELEASE SYNDROME 45 0.0022
852 THERAPEUTIC RESPONSE DECREASED 136 0.0022
853 SKIN DISCOLOURATION 103 0.0022
854 MOUTH ULCERATION 47 0.0022
855 MENTAL DISORDER 96 0.0022
856 CANDIDA INFECTION 37 0.0022
857 CHRONIC KIDNEY DISEASE 166 0.0022
858 INTENTIONAL OVERDOSE 140 0.0022
859 WITHDRAWAL SYNDROME 91 0.0022
860 NEUTROPHIL COUNT DECREASED 88 0.0022
861 LOCALISED INFECTION 52 0.0021
862 SKIN CANCER 46 0.0021
863 HYPERSOMNIA 61 0.0021
864 CARDIAC ARREST 175 0.0021
865 THROAT TIGHTNESS 57 0.0021
866 NEUTROPENIA 286 0.0021
867 LABORATORY TEST ABNORMAL 62 0.0021
868 ERYTHEMA 430 0.0021
869 TOXICITY TO VARIOUS AGENTS 352 0.0021
870 PANIC ATTACK 76 0.0021
871 DRUG PRESCRIBING ERROR 40 0.0021
872 MUSCLE TIGHTNESS 33 0.0020
873 DRUG INEFFECTIVE 2667 0.0020
874 MENTAL IMPAIRMENT 49 0.0020
875 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 47 0.0020
876 SHOCK 46 0.0020
877 HOT FLUSH 150 0.0020
878 VIRAL INFECTION 66 0.0020
879 BLOOD GLUCOSE ABNORMAL 36 0.0019
880 SEDATION 51 0.0019
881 PLASMA CELL MYELOMA 75 0.0019
882 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 49 0.0019
883 EYE PAIN 107 0.0019
884 GASTRIC DISORDER 65 0.0019
885 CONJUNCTIVITIS 35 0.0019
886 MANIA 31 0.0019
887 PAIN IN JAW 53 0.0019
888 PSYCHOMOTOR HYPERACTIVITY 31 0.0019
889 SPINAL FRACTURE 37 0.0018
890 TOOTH DISORDER 41 0.0018
891 CARDIAC DISORDER 172 0.0018
892 HAEMORRHAGE 191 0.0018
893 ANAPHYLACTIC SHOCK 47 0.0018
894 SEIZURE 209 0.0018
895 PRURITUS GENERALISED 39 0.0018
896 AGGRESSION 90 0.0018
897 STAPHYLOCOCCAL INFECTION 59 0.0018
898 KIDNEY INFECTION 35 0.0018
899 NERVOUSNESS 93 0.0018
900 THERAPEUTIC RESPONSE SHORTENED 59 0.0018
901 RASH ERYTHEMATOUS 84 0.0018
902 OVERDOSE 379 0.0018
903 UPPER LIMB FRACTURE 35 0.0018
904 CARDIAC FAILURE CONGESTIVE 141 0.0018
905 ILLNESS 180 0.0017
906 MOVEMENT DISORDER 56 0.0017
907 COMA 83 0.0017
908 SPEECH DISORDER 90 0.0017
909 DYSKINESIA 69 0.0017
910 WHITE BLOOD CELL COUNT DECREASED 184 0.0017
911 EYE SWELLING 63 0.0017
912 NEUROPATHY PERIPHERAL 161 0.0017
913 VISION BLURRED 232 0.0017
914 INCREASED APPETITE 32 0.0017
915 AGITATION 122 0.0017
916 DEMENTIA 46 0.0016
917 EYE DISORDER 54 0.0016
918 PERITONITIS 34 0.0016
919 ORAL HERPES 32 0.0016
920 INTENTIONAL DOSE OMISSION 46 0.0016
921 DYSPHONIA 94 0.0016
922 HYPOACUSIS 69 0.0016
923 DRY EYE 80 0.0016
924 RASH MACULAR 56 0.0016
925 UNRESPONSIVE TO STIMULI 41 0.0016
926 FEEDING DISORDER 32 0.0016
927 BONE MARROW FAILURE 32 0.0016
928 PSYCHOTIC DISORDER 46 0.0016
929 HIP FRACTURE 49 0.0015
930 ENCEPHALOPATHY 37 0.0015
931 RASH GENERALISED 39 0.0015
932 SUICIDE ATTEMPT 91 0.0015
933 DISEASE RECURRENCE 71 0.0015
934 DEAFNESS 39 0.0015
935 HOSPITALISATION 228 0.0015
936 NERVOUS SYSTEM DISORDER 46 0.0015
937 FEAR 38 0.0014
938 OCULAR HYPERAEMIA 63 0.0013
939 FEMUR FRACTURE 41 0.0013
940 DRUG RESISTANCE 34 0.0013
941 TREATMENT NONCOMPLIANCE 72 0.0013
942 ANGER 43 0.0013
943 ABNORMAL DREAMS 35 0.0013
944 PRODUCT SUBSTITUTION ISSUE 72 0.0012
945 FLUSHING 122 0.0012
946 MOOD SWINGS 38 0.0012
947 DISEASE PROGRESSION 141 0.0012
948 ABNORMAL BEHAVIOUR 47 0.0012
949 NEOPLASM PROGRESSION 40 0.0011
950 VISUAL ACUITY REDUCED 38 0.0011
951 FUNGAL INFECTION 38 0.0011
952 NEEDLE ISSUE 33 0.0011
953 MYELOSUPPRESSION 40 0.0011
954 ACNE 82 0.0011
955 IRRITABILITY 63 0.0010
956 CRYING 36 0.0010
957 MULTIPLE SCLEROSIS 47 0.0010
958 INCORRECT DOSE ADMINISTERED 221 0.0010
959 ABORTION SPONTANEOUS 38 0.0009
960 PRODUCT DOSE OMISSION ISSUE 275 0.0009
961 CARDIO-RESPIRATORY ARREST 39 0.0009
962 LUNG NEOPLASM MALIGNANT 38 0.0009
963 NEOPLASM MALIGNANT 61 0.0009
964 OSTEONECROSIS 30 0.0009
965 THERAPY CESSATION 45 0.0009
966 BREAST CANCER 80 0.0009
967 DEATH 707 0.0008
968 SKIN IRRITATION 37 0.0008
969 DRUG ABUSE 65 0.0008
970 THERAPEUTIC RESPONSE UNEXPECTED 35 0.0008
971 NO ADVERSE EVENT 138 0.0008
972 THERAPY INTERRUPTED 53 0.0007
973 VAGINAL HAEMORRHAGE 31 0.0007
974 INJECTION SITE SWELLING 53 0.0007
975 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 140 0.0007
976 INJECTION SITE PRURITUS 45 0.0007
977 PROSTATE CANCER 52 0.0006
978 BLOOD GLUCOSE DECREASED 31 0.0006
979 UNEVALUABLE EVENT 47 0.0006
980 EMOTIONAL DISTRESS 74 0.0006
981 EYE IRRITATION 34 0.0006
982 SURGERY 34 0.0006
983 BLADDER CANCER 34 0.0006
984 INJECTION SITE BRUISING 45 0.0006
985 INJECTION SITE PAIN 161 0.0005
986 DEVICE ISSUE 44 0.0005
987 INJECTION SITE HAEMORRHAGE 36 0.0005
988 MULTIPLE SCLEROSIS RELAPSE 30 0.0004
989 SKIN BURNING SENSATION 31 0.0004
990 INJECTION SITE ERYTHEMA 49 0.0004
991 DRUG DOSE OMISSION 41 0.0002